Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remdesivir for Long-COVID
NCT05911906Phase 4Completed
- Sponsor
- University of Derby
- Start
- Oct 2024
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of remdesivir in post-acute sequelae of SARS-CoV-2 infection (PASC), sponsored by University of Derby. Started Oct 2024; status: completed.
02
Drugs
remdesivir
03
Conditions
post-acute sequelae of SARS-CoV-2 infection (PASC)
Beyond the preview
Go deeper on NCT05911906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05911906.